| Zacks Company Profile for Masimo Corporation (MASI : NSDQ) |
|
|
| |
| • Company Description |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation.
Number of Employees: 5,600 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $162.99 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 517,019 shares |
| Shares Outstanding: 54.22 (millions) |
| Market Capitalization: $8,837.17 (millions) |
| Beta: 1.19 |
| 52 Week High: $194.88 |
| 52 Week Low: $102.12 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
1.11% |
-3.46% |
| 12 Week |
7.12% |
-9.60% |
| Year To Date |
-1.40% |
-7.35% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
Michelle Brennan - Chief Executive Officer and Chairman
Micah Young - Executive Vice President; Chief Financial Officer
Paul Hataishi - Senior Vice President; Chief Accounting Officer
Robert Chapek - Director
William Jellison - Director
|
|
Peer Information
Masimo Corporation (ABMD)
Masimo Corporation (DMDS)
Masimo Corporation (CPWY.)
Masimo Corporation (EQUR)
Masimo Corporation (ECIA)
Masimo Corporation (FMS)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 574795100
SIC: 3845
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/05/25
|
|
Share - Related Items
Shares Outstanding: 54.22
Most Recent Split Date: (:1)
Beta: 1.19
Market Capitalization: $8,837.17 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $1.14 |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $4.98 |
Payout Ratio: 0.00 |
| Number of Estimates in the Fiscal Year Consensus: 5.00 |
Change In Payout Ratio: 0.00 |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 08/05/25 |
|
|
|
| |
